Tactile Medical Q4 rev $61.7M (+4% YoY); net loss $7.5M; FY 2022 guidance $235-240M

TACTILE SYSTEMS TECHNOLOGY INC

2021-FY EPS reported -$0.60 revenue$208,057,000

Q4 revenue $61.7M (+4% YoY); full year 2021 revenue $208.1M (+11% YoY).
Q4 net loss $7.5M ($0.38 loss per share) vs net income $12.1M ($0.61 EPS) in Q4 2020.
Adjusted EBITDA Q4 $9.5M vs $10.8M prior year; full year $17.7M vs $16.0M.
FY 2022 revenue guidance $235-240M (13-15% growth) with Omicron and staffing headwinds expected in H1.
Qui tam lawsuit dismissed with no damages; board appointed Valerie Asbury and D. Brent Shafer in Jan 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.